Zhifeng He

420 total citations
22 papers, 319 citations indexed

About

Zhifeng He is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zhifeng He has authored 22 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Zhifeng He's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Zhifeng He is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Zhifeng He collaborates with scholars based in China and United States. Zhifeng He's co-authors include Dezhi Cheng, Deyao Xie, Changzheng Sun, Yi Xu, Yumei Pu, Yuxin Wang, Hong-Lin Yin, Qian Zhang, Qi Xiao and Chengwan Xia and has published in prestigious journals such as The Journal of Physical Chemistry B, Life Sciences and RSC Advances.

In The Last Decade

Zhifeng He

21 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhifeng He China 11 226 138 46 39 39 22 319
Zhanpeng Ou China 6 217 1.0× 173 1.3× 52 1.1× 90 2.3× 44 1.1× 14 348
Vinay Raj United States 10 134 0.6× 96 0.7× 50 1.1× 50 1.3× 52 1.3× 17 294
Alessandro Lavoro Italy 11 151 0.7× 106 0.8× 46 1.0× 56 1.4× 29 0.7× 19 317
Aya Matsuda Japan 7 156 0.7× 109 0.8× 24 0.5× 85 2.2× 29 0.7× 18 294
Qingxia Xu China 11 179 0.8× 76 0.6× 26 0.6× 41 1.1× 21 0.5× 35 314
Xianhai Zeng China 10 111 0.5× 69 0.5× 39 0.8× 32 0.8× 59 1.5× 33 273
Xiuwei Zhang China 11 136 0.6× 65 0.5× 110 2.4× 73 1.9× 32 0.8× 27 342
Hu Ma China 9 193 0.9× 168 1.2× 42 0.9× 69 1.8× 29 0.7× 23 292
Junhong Hu China 10 139 0.6× 72 0.5× 45 1.0× 59 1.5× 46 1.2× 19 281

Countries citing papers authored by Zhifeng He

Since Specialization
Citations

This map shows the geographic impact of Zhifeng He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifeng He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifeng He more than expected).

Fields of papers citing papers by Zhifeng He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhifeng He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifeng He. The network helps show where Zhifeng He may publish in the future.

Co-authorship network of co-authors of Zhifeng He

This figure shows the co-authorship network connecting the top 25 collaborators of Zhifeng He. A scholar is included among the top collaborators of Zhifeng He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifeng He. Zhifeng He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yuanbo, et al.. (2021). Polysaccharide-Based Lotus Seedpod Surface-Like Porous Microsphere as an Efficient Drug Carrier for Cancer Treatment. Cancer Management and Research. Volume 13. 4067–4076. 2 indexed citations
2.
Pu, Yumei, Liang Ding, Yujia Wang, et al.. (2021). Biopsy pattern of invasion type to determine the surgical approach in early-stage oral squamous cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(1). 109–119. 13 indexed citations
3.
Chen, Kun, Zhihao Yang, Xinbo Zhang, et al.. (2020). Clinical features and prognosis of primary tracheal small cell carcinoma: a population-based analysis. Translational Cancer Research. 9(2). 882–890. 1 indexed citations
4.
Chen, Kun, Zhihao Yang, Dongdong Yu, et al.. (2020). Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study. Expert Review of Gastroenterology & Hepatology. 14(6). 491–497. 5 indexed citations
5.
Zhang, Qian, Qi Xiao, Hong-Lin Yin, et al.. (2020). Milk-exosome based pH/light sensitive drug system to enhance anticancer activity against oral squamous cell carcinoma. RSC Advances. 10(47). 28314–28323. 70 indexed citations
6.
Chen, Kun, Zhihao Yang, Dongdong Yu, et al.. (2020). Survival nomogram for patients with metastatic siewert type II adenocarcinoma of the esophagogastric junction: a population-based study. Expert Review of Gastroenterology & Hepatology. 14(8). 757–764. 10 indexed citations
7.
Liu, Yu, et al.. (2019). Integrated analysis reveals five potential ceRNA biomarkers in human lung adenocarcinoma. PeerJ. 7. e6694–e6694. 16 indexed citations
8.
Zhang, Xiang, Dezhi Cheng, Yu Liu, Yuanbo Wu, & Zhifeng He. (2019). <p>Gephyrin suppresses lung squamous cell carcinoma development by reducing mTOR pathway activation</p>. Cancer Management and Research. Volume 11. 5333–5341. 4 indexed citations
9.
Wu, Yuanbo, et al.. (2019). Fistula from Congenital Subclavian Artery to Azygos Vein with Congestive Heart Failure in an Adult. Annals of Vascular Surgery. 58. 384.e1–384.e4.
10.
He, Zhifeng, et al.. (2019). NALP3 orchestrates cellular bioenergetics to facilitate non-small cell lung cancer cell growth. Life Sciences. 241. 117165–117165. 8 indexed citations
11.
Yang, Yi, et al.. (2019). MicroRNA‐488‐3p inhibits proliferation and induces apoptosis by targeting ZBTB2 in esophageal squamous cell carcinoma. Journal of Cellular Biochemistry. 120(11). 18702–18713. 26 indexed citations
13.
He, Zhifeng, et al.. (2018). Molecular Mechanism Behind the Resistance of the G1202R-Mutated Anaplastic Lymphoma Kinase to the Approved Drug Ceritinib. The Journal of Physical Chemistry B. 122(17). 4680–4692. 14 indexed citations
14.
He, Zhifeng, Yumei Pu, & Qingang Hu. (2017). [Evaluation and influencing factors of surgical margin status of oral squamous cell carcinoma].. PubMed. 52(7). 445–449. 1 indexed citations
15.
Wu, Yuanbo, et al.. (2016). PIM1 polymorphism and PIM1 expression as predisposing factors of esophageal squamous cell carcinoma in the Asian population. OncoTargets and Therapy. 9. 2919–2919. 1 indexed citations
16.
Cheng, Dezhi, Yi Xu, Changzheng Sun, & Zhifeng He. (2016). MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1. Molecular and Cellular Biochemistry. 423(1-2). 85–91. 35 indexed citations
17.
He, Zhifeng, Changzheng Sun, Yi Xu, & Dezhi Cheng. (2016). Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure. Biomedicine & Pharmacotherapy. 84. 1760–1767. 16 indexed citations
18.
He, Zhifeng, Xiaofeng Huang, Yanhong Ni, et al.. (2014). Functional toll-like receptor 3 expressed by oral squamous cell carcinoma induced cell apoptosis and decreased migration. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 118(1). 92–100. 12 indexed citations
19.
Liao, Ziwei, Lingling Zhou, Chunyan Wang, et al.. (2014). Characteristics of TCRζ , ZAP-70 , and FcɛRIγ Gene Expression in Patients with T- and NK/T-Cell Lymphoma. DNA and Cell Biology. 34(3). 201–207. 9 indexed citations
20.
He, Zhifeng, Runzhi Deng, Xiaofeng Huang, et al.. (2014). Lipopolysaccharide enhances OSCC migration by promoting epithelial–mesenchymal transition. Journal of Oral Pathology and Medicine. 44(9). 685–692. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026